Status:
COMPLETED
Avoiding Diabetes After Pregnancy Trial in Moms
Lead Sponsor:
Women's College Hospital
Collaborating Sponsors:
The Lawson Foundation
Diabetes Canada
Conditions:
Diabetes
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Mothers with previous gestational diabetes mellitus (GDM) represent a population at higher risk of future Type 2 diabetes mellitus (T2DM), which is preventable through lifestyle modification. Yet, no ...
Detailed Description
Women diagnosed with gestational diabetes mellitus (GDM) are a readily identifiable population at high risk for type 2 diabetes (T2DM) to whom preventive interventions can be offered. There is evidenc...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Physician-diagnosed Gestational Diabetes Mellitus (GDM) during most recent pregnancy based on Canadian Diabetes Association (CDA) diagnostic criteria
- 3-6 months postpartum after a GDM pregnancy
- During GDM pregnancy, followed by a Diabetes In Pregnancy clinic at one of study sites (i.e. Sunnybrook Health Sciences Centre, Mount Sinai Hospital, St. Michael's Hospital, Toronto East General Hospital)
- English-speaking
Exclusion
- Current diabetes (Type I or Type II) and/or treatment with any anti-diabetic therapy
- Any major illness that may interfere with participation
- Any obstetrical or fetal complication that may interfere with participation
- Involvement in any other clinical trial requiring drug therapy
- History of cardiovascular disease or ECG abnormalities on stress echo cardiogram
- New pregnancy within postpartum period
- Any illness affecting carbohydrate digestion and/or metabolism including kidney disease, hepatitis, HIV/AIDS, celiac disease
- Any other factor likely to limit study adherence, in the opinion of the principal investigator
- (For the Effectiveness Phase ONLY) Participation in the Pilot Phase of the ADAPT-M Study
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
345 Patients enrolled
Trial Details
Trial ID
NCT01918345
Start Date
July 1 2014
End Date
January 1 2023
Last Update
March 9 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Scarborough Health Network
Scarborough Village, Ontario, Canada, M1W 3W3
2
Michael Garron Hospital
Toronto, Ontario, Canada, M4C 5M5
3
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5
4
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8